高级检索
当前位置: 首页 > 详情页

Development and validation of prognostic nomogram for young patients with gastric cancer

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Fudan Univ, Shanghai Canc Ctr, Shanghai 200032, Peoples R China [2]Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China [3]Huazhong Univ Sci & Technol,Gastrointestinal Canc Res Inst,Dept Gastrointestinal Surg,Mol Med Ctr,Tongji Hosp,Tongji Med Coll,Wuhan 430030,Hubei,Peoples R China
出处:
ISSN:

关键词: Gastric cancer (GC) nomogram overall survival (OS) cancer-specific survival (CSS) early-onset

摘要:
Background: This study was to establish nomogram models for prognostic evaluation of early-onset gastric cancer (EOGC) in both overall survival (OS) and cancer-specific survival (CSS). Methods: EOGC patients from 2004 to 2015 were retrieved from the surveillance, epidemiology and end results (SEER) and further randomly assigned to training and validation sets. Univariate and multivariate cox analysis was used to screen out significant variables for construction of nomogram. Nomogram models were assessed by concordance index (C-index), calibration plot, receiver operating characteristics (ROCs) curve and decision curve analysis (DCA). Results: A total of 549 EOGC were selected in this process. OS nomogram was constructed based on tumor size and tumor site. CSS nomogram was constructed based on tumor size, SEER stage and tumor site. In training set, C-index for the OS nomogram was 0.688 [95% confidence intervals (95% CI): 0.629-0.747], CSS nomogram 0.785 (95% CI: 0.735-0.835). In the external validation, the C-index for the OS nomogram was 0.633 (95% CI: 0.579-0.687), while for the CSS nomogram 0.733 (95% CI: 0.686-0.780). High quality of calibration plots both in OS and OS nomogram models was noticed. Nomograms displayed a comparable result to tumor-node-metastasis (TNM) stage and SEER stage for EOGC based on DCA. Conclusions: The nomogram models provided an insightful and applicable tool to evaluate the prognosis of EOGC both in OS and CSS.

语种:
被引次数:
WOS:
PubmedID:

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Fudan Univ, Shanghai Canc Ctr, Shanghai 200032, Peoples R China [2]Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China [*1]Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
通讯作者:
通讯机构: [1]Fudan Univ, Shanghai Canc Ctr, Shanghai 200032, Peoples R China [2]Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China [*1]Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:408 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)